Advanced Oncotherapy Share Discussion Threads

[scantrader] 18/11/2016 03:52

daijavu16 Nov '16 - 08:16 - 2476 of 2483 0 0
"scantrader. What weak holder was that? Try reading the RNS properly and adding up the figures. According to the RNS there was absolutely no change in the holder's overall holding."

Brahma - the largest shareholder, and the transaction was significant enough to warrant an official RNS.

I read that as them now only having INdirect voting rights on about 90% of their shares.

Why?

I'm only speculating but one thing I suspect is that they may have pledged those shares as collateral for some non-recourse loan with some outfit like Equity First Holdings. That can be a sneaky way of getting round disclosure rules and selling down a big stake.

That's happened with several companies in recent years - Quindell being the most striking example.

Still,although I've closed most of my short here recently I've still got a small one open so I might well be prey to confirmation bias and being overly sceptical.

[daijavu] 17/11/2016 09:21

This story will end in one of two ways. Either AVO will succeed or it will be bought out for the technology.

[glibgibon] 17/11/2016 01:35

Sorting the remaining finances should sort this out - hopefully before Christmas. Probably not going to get a date on Harley Street until building is well underway. Maybe even get informed of test completion before that.

Glad to hold for another 6 months and see where things lie then.

[igbertsponk] 16/11/2016 15:01

Until they fess up to a realistic timescale to get Harley Street up and running this will continue to slide. Might even be worth me buying in a few months at this rate... not too far from my 75p (3p in old money) target.

[euroto] 16/11/2016 09:18

Thanks Waterloo. Yes I have seen and value your posts too. I have one or two concerns here but will stick for a while.

[waterloo01] 16/11/2016 08:51

euroto, yes but not in AVO. Was but have some issues (see my posts here over the last months!)

[euroto] 16/11/2016 08:49

Waterloo - you in SUMM too I see. Same as myself. Good luck to us then :-))

[daijavu] 16/11/2016 08:16

scantrader. What weak holder was that? Try reading the RNS properly and adding up the figures. According to the RNS there was absolutely no change in the holder's overall holding.

[waterloo01] 16/11/2016 08:09

Interesting read. Why do they give it no rating (paid for by AVO) and a target price of £1.26. Key risks are commercial execution and industrialisation. Financing to be sorted by year end. No date for Harley Street and China not up till 2020.

Mixed bag but a very full report.

[daijavu] 15/11/2016 23:37

This is a report on AVO done by AVO's new analysts, Goetzpartners. Required reading for all except Tom Witherington's followers who can safely ignore it because there is nothing in it to interest them:

hxxp://www.advancedoncotherapy.com/Portals/0/Documents/Investors/Financial%20Reports/Report%20AVO%20goetzpartners.pdf

[scantrader] 15/11/2016 18:43

Notice the RNS sneaked out after hours. I suppose another weak holder as far as Twirl is concerned.

[twirl] 13/11/2016 13:45

Thanks Freddy. At least it provided an opportunity for the usual suspects to eroneously cast aspersions. I suspect the aspersions about Harley St not opening until 2019 will also be proved wrong.

Still its helped a few weak holders to offload.

[freddythefish] 13/11/2016 10:34

Just a postscript to the Lord Evans (share sale) issue.

I contacted the company to ask about this, via Walbrook, their PR agency (having had some difficulty in getting any replies from other routes).

I was pleased to get a comprehensive reply which stated that Lord Evans had acted on his own, and when the company found out about the sale it was announced straight away and implied that Lord Evans was asked to resign as a result.

I also asked about any delays in prepayments from the China sales (as a consequence of possible delays in getting Harley Street up and running). The response was that Walbrook had no knowledge of any change in the expected receipt of these funds in 2017 (they cited the August 11 Hardman report as the latest, up to date record of these expectations.

(This report also emphasises that all AVO targets had so far been achieved on time/on plan).

I haven't reproduced the reply here as I was asked not to - but I haven't left anything out in the summary above.

[twirl] 09/11/2016 11:10

I doubt whether planning would have been approved otherwise - although if I recall testing of radiation will be required once constructed.
The article was also wrong by stating it will only be available for private patients as there will be 2 hours free treatment for children in the catchment area every day it is open which will also be a condition for operators of all LIGHT machines.

[vatnabrekk] 09/11/2016 10:43

Referring to the recent report in the Sunday Times, which may not have been researched as well as one might hope from such a distinguished newspaper: I believe that there is some mis-information out there regarding the amount of shielding that's required, and the level of danger from radiation etc. That may be true of the older machines, but my understanding is that there is less, perhaps no, radiation danger from the LIGHT machines. Can anyone on here verify that?

[daijavu] 08/11/2016 14:42

ramas. What do you base that statement on? Is it the fact that the share price is not going up?

[someuwin] 08/11/2016 07:29

So now Beaufort Securities have walked away / been dumped.

I've never read such bullish broker notes on a company as Beaufort used to issue on AVO.

Something looks very wrong here - imo.

[vatnabrekk] 06/11/2016 18:48

Ah yes, the good lord (no not that one, the other one!)

[vatnabrekk] 06/11/2016 18:42

When I look at the qualifications and experience of the Chairman and CEO, I would expect them to be first class at dealing with financing, shareholders, and PR generally.

[waterloo01] 06/11/2016 18:22

I have to agree, the AVO system has the potential (and that's the best word) to be best in breed. Low radiation levels and future break down costs being amongst the USP's. The issue here is in timelines and delivery. As I think one the directors stated some time back, 'what keeps me awake at night is execution risk'. No doubt bright guys,although they are exceptionally well paid and keep giving jobs to the boys, rather than a true commercial focus.

They are also being less than transparent about how they are going to secure actual sales until Harley Street is actually open, which they still say is 2017 but we know it will be 2019/20, assuming it all works and they haven't gone bust/diluted to hell by then. I think that is the main point TW is making in this piece.

Edit: The Evans story is another thing and here is something of the night about it. He sold out August/Sept, must have resigned about the same time and neither were communicated to the market for over a month as they raised funds. Red flags to me.

[vatnabrekk] 06/11/2016 18:09

I read the Sunday Times report, and I didn't pick up as much negative vibes as Shareprophets seem to have. I wonder, are we comparing like-with-like here? Is the AVO system the same as the other five or so that are expected to come on stream in the next couple of years? I somehow got the impression that the AVO system was more advanced, unique in fact. Here is an extract from their web site:


In summary, key competitive advantages of LIGHT:
Lower cost: We estimate that the cost of a LIGHT facility will be in the region of US$40m vs. US$160-200m for those using cyclotrons or synchrotrons;
Precision: The beam energy from a LIGHT machine can be varied during therapy, allowing the beam to more accurately target cancer cells and spare healthy tissues;
Compact: LIGHT will be smaller and materially lighter than conventional proton therapy solutions, significantly reducing the size and construction cost of the facility required to house it;
Modular: LIGHT will be modular in nature providing healthcare operators greater freedom to customise their service to particular treatments ie, providing lower energy accelerators for eye, head or neck treatments, and having the flexibility to increase this to higher energies through the addition of other modules;
Lower shielding requirements: LIGHT will require less shielding than conventional proton therapy solutions.

Could someone with more technical knowledge than I have, please clarify whether the AVO system is more advanced, or the same as the others?

[scantrader] 06/11/2016 13:26

Yep. And just to offset some of the ramping tripe on this thread ..